NDC Pharmacologic Class N0000000194 Somatostatin Receptor Agonists [MoA]
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
---|---|---|---|---|---|---|
0078-0180 | Sandostatin | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0181 | Sandostatin | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0182 | Sandostatin | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0633 | Signifor | Pasireotide | Injection | Subcutaneous | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0634 | Signifor | Pasireotide | Injection | Subcutaneous | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0078-0635 | Signifor | Pasireotide | Injection | Subcutaneous | Novartis Pharmaceuticals Corporation | Human Prescription Drug |
0641-6174 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0641-6175 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0641-6176 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0641-6177 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0641-6178 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Hikma Pharmaceuticals Usa Inc. | Human Prescription Drug |
0703-3301 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0703-3311 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0703-3321 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0703-3333 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
0703-3343 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Teva Parenteral Medicines, Inc. | Human Prescription Drug |
15054-1060 | Somatuline Depot | Lanreotide Acetate | Injection | Subcutaneous | Ipsen Biopharmaceuticals, Inc. | Human Prescription Drug |
15054-1090 | Somatuline Depot | Lanreotide Acetate | Injection | Subcutaneous | Ipsen Biopharmaceuticals, Inc. | Human Prescription Drug |
15054-1120 | Somatuline Depot | Lanreotide Acetate | Injection | Subcutaneous | Ipsen Biopharmaceuticals, Inc. | Human Prescription Drug |
25021-451 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Sagent Pharmaceuticals | Human Prescription Drug |
25021-452 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Sagent Pharmaceuticals | Human Prescription Drug |
25021-453 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Sagent Pharmaceuticals | Human Prescription Drug |
25021-454 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Sagent Pharmaceuticals | Human Prescription Drug |
25021-455 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Sagent Pharmaceuticals | Human Prescription Drug |
55292-131 | Signifor | Pasireotide | Injection | Subcutaneous | Recordati Rare Diseases, Inc. | Human Prescription Drug |
55292-132 | Signifor | Pasireotide | Injection | Subcutaneous | Recordati Rare Diseases, Inc. | Human Prescription Drug |
55292-133 | Signifor | Pasireotide | Injection | Subcutaneous | Recordati Rare Diseases, Inc. | Human Prescription Drug |
63323-376 | Octreotide | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-377 | Octreotide | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-378 | Octreotide | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63323-379 | Octreotide | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Fresenius Kabi Usa, Llc | Human Prescription Drug |
63629-8831 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Bryant Ranch Prepack | Human Prescription Drug |
67457-239 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Mylan Institutional Llc | Human Prescription Drug |
67457-245 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Mylan Institutional Llc | Human Prescription Drug |
67457-246 | Octreotide Acetate | Octreotide Acetate | Injection, Solution | Intravenous; Subcutaneous | Mylan Institutional Llc | Human Prescription Drug |
69097-870 | Lanreotide Acetate | Lanreotide Acetate | Injection | Subcutaneous | Cipla Usa Inc. | Human Prescription Drug |
69097-880 | Lanreotide Acetate | Lanreotide Acetate | Injection | Subcutaneous | Cipla Usa Inc. | Human Prescription Drug |
69097-890 | Lanreotide Acetate | Lanreotide Acetate | Injection | Subcutaneous | Cipla Usa Inc. | Human Prescription Drug |
69880-120 | Mycapssa | Octreotide | Capsule, Delayed Release | Oral | Chiasma Inc. | Human Prescription Drug |
There are 39 NDC products with the pharmacologic class Somatostatin Receptor Agonists [MoA].